ABBOTT LABORATORIES Increase (Decrease) in Accounts Payable and Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-02-20
- ABBOTT LABORATORIES increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $954.00M, a 167.98% increase from fiscal 2024.
- ABBOTT LABORATORIES increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $356.00M.
- ABBOTT LABORATORIES increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$760.00M, a 280.95% decline from fiscal 2022.
- ABBOTT LABORATORIES increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $420.00M, a 67.39% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|
| 2025-12-31 | $954.00M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $356.00M 10-K · filed 2026-02-20 | |
| 2023-12-31 | -$760.00M 10-K · filed 2026-02-20 | |
| 2022-12-31 | $420.00M 10-K · filed 2025-02-21 | |
| 2021-12-31 | $1.29B 10-K · filed 2024-02-16 | |
| 2020-12-31 | $1.77B 10-K · filed 2023-02-17 | |
| 2019-12-31 | $220.00M 10-K · filed 2022-02-18 | |
| 2018-12-31 | $747.00M 10-K · filed 2021-02-19 | |
| 2017-12-31 | $615.00M 10-K · filed 2020-02-21 | |
| 2016-12-31 | -$652.00M 10-K · filed 2019-02-22 | |
| 2015-12-31 | -$742.00M 10-K · filed 2018-02-16 | |
| 2014-12-31 | -$225.00M 10-K · filed 2017-02-17 | |
| 2013-12-31 | -$436.00M 10-K · filed 2016-02-19 | |
| 2012-12-31 | -$134.00M 10-K · filed 2015-02-27 | -$134.21M 10-K · filed 2013-02-15 |
| 2011-12-31 | $1.79B 10-K · filed 2014-02-21 | $1.79B 10-K · filed 2012-02-21 |
| 2010-12-31 | $572.53M 10-K · filed 2013-02-15 | |
| 2009-12-31 | -$374.71M 10-K · filed 2012-02-21 |